Revisiting the Dutch hypothesis

Journal of Allergy and Clinical Immunology

Volumn 136, Issue 3, 2015, Pages 521-529

  Postma, Dirkje S ^a   Weiss, Scott T ^b   Van Den Berge, Maarten ^a   Kerstjens, Huib A M ^a   Koppelman, Gerard H ^a,c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

allergy; Asthma; chronic obstructive pulmonary disease; Dutch hypothesis; hyperresponsiveness

Indexed keywords

ALLERGY; ARTICLE; ASTHMA; BACTERIAL INFECTION; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; EOSINOPHIL; GENETICS; HISTORY; HUMAN; HYPOTHESIS; LUNG FUNCTION; NETHERLANDS; PHARMACEUTICAL CARE; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; RISK FACTOR; AGE; BRONCHIAL HYPERREACTIVITY; GENE EXPRESSION; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; IMMUNOLOGY; PATHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

GELATINASE B; IMMUNOGLOBULIN E; MMP9 PROTEIN, HUMAN; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA1;

AGE FACTORS; ASTHMA; BRONCHIAL HYPERREACTIVITY; GENE EXPRESSION; GENE-ENVIRONMENT INTERACTION; GENOTYPE; HUMANS; IMMUNOGLOBULIN E; MATRIX METALLOPROTEINASE 9; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SEX FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84941069142     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.06.018     Document Type: Review

References (75)

1. N.G.M. Orie, and H.J. Sluiter Bronchitis I 1961 Charles C Thomas Springfield (IL)
2. C.M. Fletcher, and N.B. Pride Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the Ciba symposium Thorax 39 1984 81 85
3. H.J. Sluiter, G.H. Koeter, J.G. de Monchy, D.S. Postma, K. de Vries, and N.G. Orie The Dutch hypothesis (chronic non-specific lung disease) revisited Eur Respir J 4 1991 479 489
4. P.A. Vermeire, and N.B. Pride A "splitting" look at chronic nonspecific lung disease (CNSLD): common features but diverse pathogenesis Eur Respir J 4 1991 490 496
5. N.G. Orie, H.J. Sluiter, K. De Vries, and G.J. Tammelings Chronic nonspecific respiratory diseases Ned Tijdschr Geneeskd 105 1961 2136 2139
6. N.G.M. Orie, and H.J. Sluiter Bronchitis II 1964 Charles C Thomas Springfield (IL)
7. D.S. Postma, M. Kerkhof, H.M. Boezen, and G.H. Koppelman Asthma and chronic obstructive pulmonary disease: common genes, common environments? Am J Respir Crit Care Med 183 2011 1588 1594
8. X. Li, G.A. Hawkins, E.J. Ampleford, W.C. Moore, H. Li, A.T. Hastie, and et al. Genome-wide association study identifies TH1 pathway genes associated with lung function in asthmatic patients J Allergy Clin Immunol 132 2013 313 320
9. J. Smolonska, G.H. Koppelman, C. Wijmenga, J.M. Vonk, P. Zanen, M. Bruinenberg, and et al. Common genes underlying asthma and COPD? Genome-wide analysis on the Dutch hypothesis Eur Respir J 44 2014 860 872
10. M. Hardin, M. Cho, M.L. McDonald, T. Beaty, J. Ramsdell, S. Bhatt, and et al. The clinical and genetic features of COPD-asthma overlap syndrome Eur Respir J 44 2014 341 350
11. G.T. O'Connor, D. Sparrow, and S.T. Weiss The role of allergy and nonspecific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease Am Rev Respir Dis 140 1989 225 252
12. P.J. Gergen, and P.C. Turkeltaub The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976-80 (NHANES II) J Allergy Clin Immunol 90 1992 579 588
13. X. Wang, T.T. Mensinga, J.P. Schouten, B. Rijcken, and S.T. Weiss Determinants of maximally attained level of pulmonary function Am J Respir Crit Care Med 169 2004 941 949
14. D.F. Jansen, J.P. Schouten, J.M. Vonk, B. Rijcken, W. Timens, J. Kraan, and et al. Smoking and airway hyperresponsiveness especially in the presence of blood eosinophilia increase the risk to develop respiratory symptoms: a 25-year follow-up study in the general adult population Am J Respir Crit Care Med 160 1999 259 264
15. J.J. Hospers, J.P. Schouten, S.T. Weiss, D.S. Postma, and B. Rijcken Eosinophilia is associated with increased all-cause mortality after a follow-up of 30 years in a general population sample Epidemiology 11 2000 261 268
16. D.F. Jansen, B. Rijcken, J.P. Schouten, J. Kraan, S.T. Weiss, W. Timens, and et al. The relationship of skin test positivity, high serum total IgE levels, and peripheral blood eosinophilia to symptomatic and asymptomatic airway hyperresponsiveness Am J Respir Crit Care Med 159 1999 924 931
17. R.C. Strunk, S.T. Weiss, K.P. Yates, J. Tonascia, R.S. Zeiger, and S.J. Szefler Mild to moderate asthma affects lung growth in children and adolescents J Allergy Clin Immunol 118 2006 1040 1047
18. H.A. Kerstjens, S.E. Overbeek, J.P. Schouten, P.L. Brand, and D.S. Postma Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled corticosteroid treatment. Dutch CNSLD Study Group Eur Respir J 6 1993 868 876
19. F. Fattahi, N.H. ten Hacken, C.G. Lofdahl, M.N. Hylkema, W. Timens, D.S. Postma, and et al. Atopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP study Respir Res 14 2013 10
20. D.P. Tashkin, M.D. Altose, E.R. Bleecker, J.E. Connett, R.E. Kanner, W.W. Lee, and et al. The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group Am Rev Respir Dis 145 1992 301 310
21. X. Xu, B. Rijcken, J.P. Schouten, and S.T. Weiss Airways responsiveness and development and remission of chronic respiratory symptoms in adults Lancet 350 1997 1431 1434
22. N.B. Pride, R.G. Taylor, T.K. Lim, H. Joyce, and A. Watson Bronchial hyperresponsiveness as a risk factor for progressive airflow obstruction in smokers Bull Eur Physiopathol Respir 23 1987 369 375
23. P. Lange, S. Groth, G.J. Nyboe, J. Mortensen, M. Appleyard, G. Jensen, and et al. Effects of smoking and changes in smoking habits on the decline of FEV1 Eur Respir J 2 1989 811 816
24. J.E. McDonough, R. Yuan, M. Suzuki, N. Seyednejad, W.M. Elliott, P.G. Sanchez, and et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease N Engl J Med 365 2011 1567 1575
25. C.J. Galban, M.K. Han, J.L. Boes, K.A. Chughtai, C.R. Meyer, T.D. Johnson, and et al. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression Nat Med 18 2012 1711 1715
26. J.K. Peat, C.M. Salome, C.S. Sedgwick, J. Kerrebijn, and A.J. Woolcock A prospective study of bronchial hyperresponsiveness and respiratory symptoms in a population of Australian schoolchildren Clin Exp Allergy 19 1989 299 306
27. S.S. Braman, A.A. Barrows, B.A. DeCotiis, G.A. Settipane, and W.M. Corrao Airway hyperresponsiveness in allergic rhinitis. A risk factor for asthma Chest 91 1987 671 674
28. H. Bisgaard, S.M. Jensen, and K. Bonnelykke Interaction between asthma and lung function growth in early life Am J Respir Crit Care Med 185 2012 1183 1189
29. J.K. Peat, A.J. Woolcock, and K. Cullen Rate of decline of lung function in subjects with asthma Eur J Respir Dis 70 1987 171 179
30. P.J. Brown, H.W. Greville, and K.E. Finucane Asthma and irreversible airflow obstruction Thorax 39 1984 131 136
31. P. Albert, A. Agusti, L. Edwards, R. Tal-Singer, J. Yates, P. Bakke, and et al. Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease Thorax 67 2012 701 708
32. D.S. Postma, and H.A. Kerstjens Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease Am J Respir Crit Care Med 158 1998 S187 S192
33. J.C. Hogg, F. Chu, S. Utokaparch, R. Woods, W.M. Elliott, L. Buzatu, and et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease N Engl J Med 350 2004 2645 2653
34. J. Vestbo, L.D. Edwards, P.D. Scanlon, J.C. Yates, A. Agusti, P. Bakke, and et al. Changes in forced expiratory volume in 1 second over time in COPD N Engl J Med 365 2011 1184 1192
35. B. Rijcken Bronchial responsiveness and COPD risk: an epidemiological study [doctoral dissertation] 1991 University of Groningen Groningen (The Netherlands)
36. P.M. O'Byrne, and D.S. Postma The many faces of airway inflammation. Asthma and chronic obstructive pulmonary disease. Asthma Research Group Am J Respir Crit Care Med 159 1999 S41 S63
37. N.R. Anthonisen, and E.C. Wright Bronchodilator response in chronic obstructive pulmonary disease Am Rev Respir Dis 133 1986 814 819
38. P.M. Calverley, P. Albert, and P.P. Walker Bronchodilator reversibility in chronic obstructive pulmonary disease: use and limitations Lancet Respir Med 1 2013 564 573
39. H.A. Kerstjens, P.L. Brand, M.D. Hughes, N.J. Robinson, D.S. Postma, H.J. Sluiter, and et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group N Engl J Med 327 1992 1413 1419
40. D.S. Postma, A. Bush, and M. Van den Berge Risk factors and early origins of chronic obstructive pulmonary disease Lancet 385 2015 899 909
41. M. Van den Berge, N.H. ten Hacken, E. van der Wiel, and D.S. Postma Treatment of the bronchial tree from beginning to end: targeting small airway inflammation in asthma Allergy 68 2013 16 26
42. M. Van den Berge, J.M. Vonk, M. Gosman, T.S. Lapperre, J.B. Snoeck-Stroband, P.J. Sterk, and et al. Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD Eur Respir J 40 2012 1098 1105
43. D.S. Postma, J.B. Wempe, T.E. Renkema, T.W. Van Der Mark, and G.H. Koeter Hyperresponsiveness as a determinant of the outcome in chronic obstructive pulmonary disease Am Rev Respir Dis 143 1991 1458 1462
44. E.H. Ramsdale, and F.E. Hargreave Differences in airway responsiveness in asthma and chronic airflow obstruction Med Clin North Am 74 1990 741 751
45. D.P. Tashkin, M.D. Altose, J.E. Connett, R.E. Kanner, W.W. Lee, and R.A. Wise Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group Am J Respir Crit Care Med 153 1996 1802 1811
46. C.E. Brightling Eosinophils, bronchitis and asthma: pathogenesis of cough and airflow obstruction Pulm Pharmacol Ther 24 2011 324 327
47. M. Van den Berge, R.J. Meijer, H.A. Kerstjens, D.M. de Reus, G.H. Koeter, H.F. Kauffman, and et al. PC(20) adenosine 5′-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine Am J Respir Crit Care Med 163 2001 1546 1550
48. M. Broekema, W. Timens, J.M. Vonk, F. Volbeda, M.E. Lodewijk, M.N. Hylkema, and et al. Persisting remodeling and less airway wall eosinophil activation in complete remission of asthma Am J Respir Crit Care Med 183 2011 310 316
49. C.E. Brightling, S. McKenna, B. Hargadon, S. Birring, R. Green, R. Siva, and et al. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease Thorax 60 2005 193 198
50. R. Siva, R.H. Green, C.E. Brightling, M. Shelley, B. Hargadon, S. McKenna, and et al. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial Eur Respir J 29 2007 906 913
51. E. Bathoorn, J.J. Liesker, D.S. Postma, G.H. Koeter, M. van der Toorn, S. van der Heide, and et al. Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation Int J Chron Obstruct Pulmon Dis 4 2009 101 109
52. J.J. Liesker, E. Bathoorn, D.S. Postma, J.M. Vonk, W. Timens, and H.A. Kerstjens Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD Respir Med 105 2011 1853 1860
53. M.A. Ghebre, M. Bafadhel, D. Desai, S.E. Cohen, P. Newbold, L. Rapley, and et al. Biological clustering supports both "Dutch" and "British" hypotheses of asthma and chronic obstructive pulmonary disease J Allergy Clin Immunol 135 2015 63 72
54. M. Hilty, C. Burke, H. Pedro, P. Cardenas, A. Bush, C. Bossley, and et al. Disordered microbial communities in asthmatic airways PLoS One 5 2010 e8578
55. H. Bisgaard, M.N. Hermansen, F. Buchvald, L. Loland, L.B. Halkjaer, K. Bonnelykke, and et al. Childhood asthma after bacterial colonization of the airway in neonates N Engl J Med 357 2007 1487 1495
56. M.K. Han, Y.J. Huang, J.J. Lipuma, H.A. Boushey, R.C. Boucher, W.O. Cookson, and et al. Significance of the microbiome in obstructive lung disease Thorax 67 2012 456 463
57. J.K. Sont, L.N. Willems, E.H. Bel, J.H. van Krieken, J.P. Vandenbroucke, and P.J. Sterk Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group Am J Respir Crit Care Med 159 1999 1043 1051
58. S.M. Koenig, J.J. Murray, J. Wolfe, L. Andersen, S. Yancey, B. Prillaman, and et al. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma? Respir Med 102 2008 665 673
59. M. Nuijsink, W.C. Hop, P.J. Sterk, E.J. Duiverman, and J.C. de Jongste Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial Eur Respir J 30 2007 457 466
60. S.R. Rutgers, G.H. Koeter, T.W. Van Der Mark, and D.S. Postma Short-term treatment with budesonide does not improve hyperresponsiveness to adenosine 5′-monophosphate in COPD Am J Respir Crit Care Med 157 1998 880 886
61. D. Loppow, M.B. Schleiss, F. Kanniess, C. Taube, R.A. Jorres, and H. Magnussen In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation Respir Med 95 2001 115 121
62. R.H. Green, C.E. Brightling, S. McKenna, B. Hargadon, D. Parker, P. Bradding, and et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial Lancet 360 2002 1715 1721
63. P.S. Burge, P.M. Calverley, P.W. Jones, S. Spencer, J.A. Anderson, and T.K. Maslen Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial BMJ 320 2000 1297 1303
64. R.A. Pauwels, C.G. Lofdahl, L.A. Laitinen, J.P. Schouten, D.S. Postma, N.B. Pride, and et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease N Engl J Med 340 1999 1948 1953
65. P.M. Calverley, J.A. Anderson, B. Celli, G.T. Ferguson, C. Jenkins, P.W. Jones, and et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Engl J Med 356 2007 775 789
66. T.S. Lapperre, J.B. Snoeck-Stroband, M.M. Gosman, D.F. Jansen, S.A. van, H.A. Thiadens, and et al. Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial Ann Intern Med 151 2009 517 527
67. R. Leigh, M.M. Pizzichini, M.M. Morris, F. Maltais, F.E. Hargreave, and E. Pizzichini Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment Eur Respir J 27 2006 964 971
68. M. Bafadhel, S. McKenna, S. Terry, V. Mistry, M. Pancholi, P. Venge, and et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial Am J Respir Crit Care Med 186 2012 48 55
69. S.A. Christenson, K. Steiling, M. van den Berge, K. Hijazi, P.S. Hiemstra, D.S. Postma, and et al. Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease Am J Respir Crit Care Med 191 2015 758 766
70. E.H. Wong, J.D. Porter, M.R. Edwards, and S.L. Johnston The role of macrolides in asthma: current evidence and future directions Lancet Respir Med 2 2014 657 670
71. R.K. Albert, J. Connett, W.C. Bailey, R. Casaburi, J.A. Cooper Jr., G.J. Criner, and et al. Azithromycin for prevention of exacerbations of COPD N Engl J Med 365 2011 689 698
72. A.E. Dijkstra, D.S. Postma, H.N. Ten, J.M. Vonk, M. Oudkerk, P.M. van Ooijen, and et al. Low-dose CT measurements of airway dimensions and emphysema associated with airflow limitation in heavy smokers: a cross sectional study Respir Res 14 2013 11
73. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention: NHLBI/WHO workshop report. Revised 2014. Available at: www.ginasthma.org. Accessed April 2015.
74. Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2014. Available at: www.ginasthma.org. Accessed April 2015.
75. V.E. Ortega, G.A. Hawkins, W.C. Moore, A.T. Hastie, E.J. Ampleford, W.W. Busse, and et al. Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting beta agonist treatment in a multiethnic asthma population: a genetic study Lancet Respir Med 2 2014 204 213